Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03950427 · ClinicalTrials.gov registry record · Phase 4
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
A Phase 4 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 131
- Enrollment target
NCT03950427 is a Phase 4 study that has completed, run by University of California, San Francisco. The registered enrollment target is 131 participants.
The verdict
NCT03950427, a Phase 4 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 131 participants
- Enrollment target
Study Summary
This is a research study about a smoking cessation program tailored for adults with serious mental illness (SMI). The program uses a Videogame-based Physical (VIP) activity, smoking cessation counseling, and medication (bupropion),
Interventions
- BEHAVIORAL Counseling
- DRUG Bupropion
- BEHAVIORAL Videogame-based physical activity
- BEHAVIORAL Sedentary videogame
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2019-07-08 |
| Est. Completion | 2025-07-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03950427
The ClinicalTrials.gov registry entry for NCT03950427 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Counseling is the first listed.
NCT03950427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03950427 about?
NCT03950427 is a clinical study titled "PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness". This is a research study about a smoking cessation program tailored for adults with serious mental illness (SMI). The program uses a Videogame-based Physical (VIP) activity, smoking cessation counseling, and medication (bupropion),
What is the current status of trial NCT03950427?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2019-07-08. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT03950427?
The interventions under investigation include: Counseling (BEHAVIORAL), Bupropion (DRUG), Videogame-based physical activity (BEHAVIORAL), Sedentary videogame (BEHAVIORAL).
Who is sponsoring clinical trial NCT03950427?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.